Detection of Intergenerational Genetic Effects with Application to HLA-B Matching as a Risk Factor for SchizophreniaChilds E.J.a · Sobel E.M.b · Palmer C.G.S.b, c · Sinsheimer J.S.a, b, d
Departments of aBiostatistics, bHuman Genetics, cPsychiatry and Biobehavioral Sciences, and dBiomathematics, University of California, Los Angeles, Calif., USA
Christina Palmer, PhD
UCLA Semel Institute
760 Westwood Plaza, Room 47-422, Los Angeles, CA 90095 (USA)
Tel. +1 310 794 4796, E-Mail firstname.lastname@example.org
Janet Sinsheimer, PhD
UCLA Gonda Center
695 Charles E. Young Drive South, 5357-C
Los Angeles, CA 90095 (USA)
Tel. +1 310 825 8002, E-Mail email@example.com
Keywords: Family-based associationMaternal-fetal genotype testExtended maternal-fetal genotype testGenotype interactionsComplex diseaseOlfactory deficitsGene-by-geneGene-by-environmentMajor histocompatibility complex
Do you have an account?
Background and Methods: Association studies using unrelated individuals cannot detect intergenerational genetic effects contributing to disease. To detect these effects, we improve the extended maternal-fetal genotype (EMFG) incompatibility test to estimate any combination of maternal effects, offspring effects, and their interactions at polymorphic loci or multiple SNPs, using any size pedigrees. We explore the advantages of using extended pedigrees rather than nuclear families. We apply our methods to schizophrenia pedigrees to investigate whether the previously associated mother-daughter HLA-B matching is a genuine risk or the result of bias. Results: Simulations demonstrate that using the EMFG test with extended pedigrees increases power and precision, while partitioning extended pedigrees into nuclear families can underestimate intergenerational effects. Application to actual data demonstrates that mother-daughter HLA-B matching remains a schizophrenia risk factor. Furthermore, ascertainment and mate selection biases cannot by themselves explain the observed HLA-B matching and schizophrenia association. Conclusions: Our results demonstrate the power of the EMFG test to examine intergenerational genetic effects, highlight the importance of pedigree rather than case/control or case-mother/control-mother designs, illustrate that pedigrees provide a means to examine alternative, non-causal mechanisms, and they strongly support the hypothesis that HLA-B matching is causally involved in the etiology of schizophrenia in females.
© 2011 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.